Healthcare • Biotechnology
EODHD (TTM) · as of Oct 13, 2026
End-of-day close from stored market data, not a live quote.
Sign in to see your position size
We’ll show you if RARE is in your portfolio and how much it contributes.
Sign inLoading market dates
No upcoming ex-dividend date announced
No 8-K filings in the last 30 days.
45 top institutions tracked
Last 13F trend: accumulating (heavy)
Unlock crowding heatmapUnlock filer discoverySentiment: bearish
Last trade: sell 30 days ago
Red flags: 0
311 filers reported a long position in RARE for Q2 2026. 13-F holdings are filed up to 45 days after the quarter ends.
| Holder | Value | Shares | Shares vs Q1 2026 |
|---|---|---|---|
| BlackRock, Inc. | $355.7M | 10.7M | +46% |
| RTW INVESTMENTS, LP | $260.3M | 7.8M | +113.7% |
| VANGUARD PORTFOLIO MANAGEMENT LLC | $226.7M | 6.8M | +26.1% |
| AQR CAPITAL MANAGEMENT LLC | $214.1M | 6.6M | +43.3% |
| STATE STREET CORP | $205.6M | 6.2M | +22.6% |
| VANGUARD CAPITAL MANAGEMENT LLC | $143.5M | 4.3M | +2.5% |
| TWO SIGMA INVESTMENTS, LP | $120.9M | 3.6M | +64.2% |
| SANDS CAPITAL MANAGEMENT, LLC | $105.5M | 3.2M | -1.7% |
| JACOBS LEVY EQUITY MANAGEMENT, INC | $98.2M | 2.9M | +105.4% |
| FRONTIER CAPITAL MANAGEMENT CO LLC | $95.1M | 2.8M | +30% |
Unlock detailed insider transactions, institutional holder changes, factor exposures, and personalized alerts. Start free with your own portfolio.